Engineered plant extracellular vesicles for autoimmune diseases therapy
R Han, Y Wu, Y Han, X Liu, H Liu, J Su - Nano Research, 2024 - Springer
Autoimmune diseases (AID) encompass a diverse array of conditions characterized by
immune system dysregulation, resulting in aberrant responses of B cells and T cells against …
immune system dysregulation, resulting in aberrant responses of B cells and T cells against …
[HTML][HTML] Platelets in multiple sclerosis: early and central mediators of inflammation and neurodegeneration and attractive targets for molecular imaging and site …
JM Orian, CS D'Souza, P Kocovski, G Krippner… - Frontiers in …, 2021 - frontiersin.org
Platelets are clearly central to thrombosis and hemostasis. In addition, more recently,
evidence has emerged for non-hemostatic roles of platelets including inflammatory and …
evidence has emerged for non-hemostatic roles of platelets including inflammatory and …
Helminth therapy and multiple sclerosis
JO Fleming - International journal for parasitology, 2013 - Elsevier
Multiple sclerosis is a common and frequently disabling neurological disease of young
adults. It is characterised by recurrent areas of focal inflammation (plaques) in the CNS …
adults. It is characterised by recurrent areas of focal inflammation (plaques) in the CNS …
MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis
MicroRNA (miRNA) are small non-coding RNA molecules about 21–25 nucleotides long.
They control gene regulation by translational repression and cleavage. Several studies have …
They control gene regulation by translational repression and cleavage. Several studies have …
The meninges: new therapeutic targets for multiple sclerosis
AE Russi, MA Brown - Translational Research, 2015 - Elsevier
The central nervous system (CNS) largely comprises nonregenerating cells, including
neurons and myelin-producing oligodendrocytes, which are particularly vulnerable to …
neurons and myelin-producing oligodendrocytes, which are particularly vulnerable to …
Experimental models of multiple sclerosis
AR Pachner - Current opinion in neurology, 2011 - journals.lww.com
Experimental models of multiple sclerosis : Current Opinion in Neurology Experimental models
of multiple sclerosis : Current Opinion in Neurology Log in or Register Subscribe to …
of multiple sclerosis : Current Opinion in Neurology Log in or Register Subscribe to …
[HTML][HTML] Potential utility of natural products against oxidative stress in animal models of multiple sclerosis
Z Zha, S Liu, Y Liu, C Li, L Wang - Antioxidants, 2022 - mdpi.com
Multiple sclerosis (MS) is an autoimmune-mediated degenerative disease of the central
nervous system (CNS) characterized by immune cell infiltration, demyelination and axonal …
nervous system (CNS) characterized by immune cell infiltration, demyelination and axonal …
Critical appraisal of animal models of multiple sclerosis
D Baker, W Gerritsen, J Rundle… - Multiple Sclerosis …, 2011 - journals.sagepub.com
Experimental autoimmune encephalomyelitis (EAE) is a spectrum of neurological disorders
in laboratory animals that is used to model multiple sclerosis (MS). However, few agents …
in laboratory animals that is used to model multiple sclerosis (MS). However, few agents …
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis
A Ridderstad Wollberg… - Proceedings of the …, 2014 - National Acad Sciences
One hallmark of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis
(EAE) is infiltration of leukocytes into the CNS, where chemokines and their receptors play a …
(EAE) is infiltration of leukocytes into the CNS, where chemokines and their receptors play a …
MicroRNAs and multiple sclerosis
KU Tufekci, MG Oner, S Genc, K Genc - Autoimmune diseases, 2011 - Wiley Online Library
MicroRNAs (miRNAs) have recently emerged as a new class of modulators of gene
expression. miRNAs control protein synthesis by targeting mRNAs for translational …
expression. miRNAs control protein synthesis by targeting mRNAs for translational …